Dr. David Cowburn's lab at the Albert Einstein College of Medicine explores how the dynamic behaviors of disordered proteins influence their roles in various biological processes. By employing advanced techniques like NMR spectroscopy and molecular simulations, the lab is focusing on the nuclear pore complex and the engineering of proteins through inteins for therapeutic applications. This research is significant for understanding diseases like cancer and neurodegeneration, and may lead to new methods for targeted drug delivery.

Dr. Hannele Ruohola-Baker's lab at the University of Washington focuses on understanding the genetic factors involved in craniofacial disorders, such as cleft lip and palate, to develop targeted therapies. They use advanced techniques like spatial transcriptomics to study human tissues and induced pluripotent stem cells to model these disorders. This research aims to reveal the complex networks that control the development of the face and improve treatment options for common birth defects.

Dr. Craig M. Crews leads a research lab at Yale University focused on innovative methods to treat diseases like Sickle Cell Disease (SCD) and certain cancers. His team explores new drugs that can degrade problematic proteins that contribute to these diseases, making it easier to target challenging medical conditions. By developing small molecules that induce the degradation of specific proteins, they aim to improve treatment effectiveness and create more targeted therapies.

Dr. Christina M Hull's lab at the University of Wisconsin-Madison focuses on understanding the biology of Cryptococcus, a fungus that causes serious diseases, especially in people with weakened immune systems. The lab studies how Cryptococcus spores germinate and grow, aiming to uncover new ways to develop antifungal treatments. By exploring the interactions between these fungal spores and the human immune system, the research seeks to identify potential therapeutic targets that could help prevent or treat lethal fungal infections.

Dr. Angelo D'Alessandro's lab focuses on understanding how red blood cells age and respond to oxidative stress, which is crucial for oxygen transport in the human body. The lab investigates the process of ferroptosis, a unique form of cell death that occurs in response to iron-induced oxidative damage. By studying both in vivo and in vitro models, the research aims to uncover how this process affects red blood cell health and storage, with implications for blood transfusions and overall human health.

Dr. Rhiju Das's lab at Stanford University specializes in understanding RNA molecules, which are essential for many biological processes including diseases and immune responses. The team employs advanced techniques such as modeling, electron microscopy, and machine learning to design and visualize complex RNA structures. Their research not only addresses fundamental scientific questions but also aims to develop novel therapies and vaccines against diseases like COVID-19 by targeting RNA.

Dr. Teresa Davoli's lab focuses on understanding how DNA mutations occur in human cells and their role in diseases like cancer. The lab develops a novel system called MutSensor, which allows for precise measurement of mutation rates in mammalian cells. By identifying the genes that control these mutations, the research aims to uncover fundamental mechanisms of genome stability, contributing valuable insights for public health and disease prevention.

Dr. Enrique M De La Cruz's lab at Yale University focuses on understanding the dynamics of actin filaments, which are crucial for cell movement and other essential processes in eukaryotic cells. The lab combines biochemical and biophysical techniques to explore how actin networks are built, remodeled, and recycled, and how these processes are regulated by various proteins. This research not only sheds light on fundamental cellular functions but also has implications for understanding diseases related to cell motility.

Erik Debler's lab at Thomas Jefferson University studies a type of parasite called the African trypanosome, which causes serious diseases like sleeping sickness. The team focuses on understanding how this parasite regulates its genes using special enzymes that modify DNA. By uncovering these mechanisms, they hope to find new treatments for infections caused by these parasites, which affect millions of people worldwide.

Professor Matthew David Macmanes at the University of New Hampshire studies why some rodents can survive with very little water. His lab focuses on understanding the biological and genetic factors that allow these animals to tolerate dehydration. The goal of the research is to apply this knowledge to improve human health, particularly for vulnerable populations who suffer from dehydration. By learning how these rodents manage water loss and preserve organ function, the lab aims to find new ways to help humans cope with dehydration-related health risks.

Dr. Marina Gorbatyuk's lab focuses on developing new therapies for diabetic retinopathy, a significant cause of vision loss in adults. The lab is investigating the use of small molecules called RXR agonists, which can target damaged retinal cells and may help reduce inflammation and improve lipid metabolism in the retina. By using innovative drug delivery methods directly to the retina, the lab aims to create sustainable treatments for this condition and understand how these treatments work at both the cellular and molecular levels.

Dr. Michael M. Cox's lab at the University of Wisconsin-Madison focuses on understanding how the DNA replication process works, especially when it gets interrupted by damages. They study the gaps that are left behind when DNA is copied incorrectly and how these gaps can lead to problems like cancer and antibiotic resistance in bacteria. The lab combines techniques from biochemistry, genetics, and molecular biology to explore these important issues and aim to find new ways to mitigate genomic instability and antibiotic resistance.

Dr. Patrick Sung's lab studies the intricate mechanisms by which cells repair harmful DNA damage, specifically focusing on a critical repair process called homology-directed repair (HDR). By understanding how various proteins interact to facilitate or inhibit this process, the lab aims to uncover insights into cancer biology, particularly regarding how the failure of these repair pathways can lead to tumor development. Their research is aimed at developing new therapeutic strategies for treating cancers associated with defects in DNA repair processes.

Dr. Dale Ramsden's lab at the University of North Carolina focuses on understanding how DNA polymerase theta contributes to genome stability and its role in cancer. Using a multidisciplinary approach, the lab looks into the mechanisms of DNA damage repair, particularly in BRCA-deficient cancers, and seeks to identify ways to selectively target these vulnerabilities to develop more effective cancer therapies. Their research combines molecular biology with structural biology and biophysics to inform clinical applications.

Dr. Timothy Lohman's research lab focuses on understanding how specific proteins help maintain the genetic material in cells. Their work centers around DNA helicases and single-stranded DNA binding proteins, which are crucial for processes like DNA replication and repair. By studying the mechanisms of these proteins, the lab aims to uncover insights that could lead to the development of new treatments for diseases caused by mutations in these proteins.

Dr. Joseph J. Loparo's research lab at Harvard Medical School focuses on understanding how cells repair damaged DNA, specifically through a process called non-homologous end joining (NHEJ). This repair mechanism is crucial for maintaining genomic integrity, and understanding it can have implications for cancer treatment and gene therapy. By using advanced imaging techniques, the lab investigates the molecular details of how DNA ends are fixed and how errors can occur during this process, leading to potential diseases.

Dr. Zhao Wang's lab at Baylor College of Medicine focuses on understanding how certain bacterial proteins known as efflux pumps help bacteria resist antibiotics. By studying the structure and assembly of these pumps using advanced imaging techniques, the lab aims to uncover the mechanisms behind multidrug resistance in pathogens like E. coli. This research is crucial for developing new strategies to combat antibiotic resistance, a significant public health threat.

Professor Edward H. Egelman's lab at the University of Virginia focuses on understanding the structures of various helical proteins and nucleoprotein polymers using advanced cryo-electron microscopy techniques. The lab studies a range of biological materials, from pathogenic bacterial filaments involved in diseases to viruses that infect extremophiles. Their research not only aims to elucidate fundamental aspects of these structures but also explores potential biomedical applications related to human health.

Dr. Sherine F. Elsawa's lab focuses on understanding how a specific protein called GLI2 helps control the production of antibodies by B cells, which are essential for our immune response. The lab uses both special human B cell lines and genetically modified mice to explore how GLI2 affects the transcription of immunoglobulin genes, which are vital in responding to infections and diseases. This research is particularly important for understanding immune disorders where antibody production goes awry, like certain autoimmune diseases and cancers.

Dr. Wenbo Li's lab at the University of Texas Health Science Center focuses on understanding the role of enhancer RNAs in regulating brain genes and their connections to Alzheimer's disease. By investigating how these noncoding RNAs function and affect gene expression, the lab aims to uncover new molecular mechanisms behind Alzheimer's, which could lead to better diagnostic tools and treatments.